๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation

โœ Scribed by Michael A. Zimmerman; Mara A. Kelly; Jeffrey Campsen; M. Susan Mandell; Michael Wachs; Tom Bak; Afshin Skibba; Brian Lancaster; Igal Kam

Book ID
110890301
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
82 KB
Volume
24
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tumor recurrence following liver transpl
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
โœ Aileen E. Marshall; Simon M. Rushbrook; Sarah L. Vowler; Christopher R. Palmer; ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 297 KB

The selection of patients with hepatocellular carcinoma for liver transplantation is currently based on the size and number of tumors to minimize the risk of recurrence. These criteria measure tumor bulk but may not reflect tumor behavior accurately. A biological marker of tumor behavior could aid w

Impact of sirolimus on the recurrence of
Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
โœ Srinath Chinnakotla; Gary L. Davis; Sugam Vasani; Peter Kim; Koji Tomiyama; Edmu ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 1 views

Tumor recurrence after liver transplantation for hepatocellular carcinoma is associated with a poor prognosis. Because immunosuppression is a well-known risk factor for tumor growth, it is surprising that its possible role in the outcome of liver transplantation has been poorly evaluated. We perform